Coronavirus
The latest news and information about the 2019-20 coronavirus pandemic as it relates to community pharmacy.
Access C+D’s coronavirus hub to stay up to date with the most recent COVID-19 developments, and community pharmacy’s role in tackling the outbreak.
The previous health secretary revealed NHSE’s “lack of enthusiasm” in supporting community pharmacy is “inbuilt” and it is “by tradition, really very tight on pharmacists” during his evidence at the latest Covid-19 Inquiry hearing.
The national commissioner plans to “stand up” community pharmacy in a future pandemic situation if vaccination rollout needs to be “augmented”, it has revealed.
NHS England (NHSE) has revealed the autumn adult flu vaccination programme start date, while instructing pharmacies to secure alternatives to one unavailable vaccine.
Confirmation of the unchanging fees comes as NHS England (NHSE) has asked pharmacies to prepare for the autumn flu and COVID-19 vaccination programmes to start in October, or September for pregnant women.
The new private COVID-19 vaccine, manufactured by Novavax and delivered for the first time in the UK by an independent pharmacy, is almost half the price of the Pfizer jab offered by Boots.
The multiple will offer private Pfizer vaccines for “32% more” than independent pharmacies, C+D has learned.
Pfizer-BioNTech’s Comirnaty COVID-19 vaccine will be available for sale to the public from March, Pfizer announced on Friday February 9.
A possible COVID-19 spring booster campaign would see pharmacies paid an additional £2.50 per jab, NHS England (NHSE) has announced.
Community pharmacies are set to pioneer the UK’s first private COVID-19 vaccinations, C+D has learned.
Four industry insiders explain why they are providing NHS COVID-19 vaccines this season – despite a challenging backdrop of funding pressures and capacity constraints
Thousands more pharmacies in England will offer a COVID-19 vaccination service this season despite slashed fees and a confusing start to the programme, C+D has learned.
COVID-19 vaccine manufacturers are “exploring” the potential of providing their jabs privately, C+D has learned.